SEARCH

SEARCH BY CITATION

References

  • 1
    United Nations. World Population Prospects: the 1992 Revision. New York, USA: United Nations, 1993.
  • 2
    Greenwald DA. Aging, the gastrointestinal tract, and risk of acid-related disease. Am J Med 2004; 117 (Suppl. 5A): S8S13.
  • 3
    Feldman M, Cryer B, McArthur KE, et al. Effects of aging and gastritis on gastric acid an pepsin secretion in humans: a prospective study. Gastroenterology 1996; 110: 104352.
  • 4
    Pilotto A. Aging and the gastrointestinal tract. Ital J Gastroenterol Hepatol 1999; 31: 13753.
  • 5
    Kemppainen H, Raiha I, Sourander L. Clinical presentation of peptic ulcer in the elderly. Gerontology 1997; 43: 2838.
  • 6
    Fuchs SC, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 3241.
  • 7
    Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 (Suppl. 1): S11628.
  • 8
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 9
    Gisbert JP, Khorrami S, Carballo F, et al. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004; 19: 61729.
  • 10
    Rinaldi V, Zullo A. Duodenal stenosis and Helicobacter pylori. J Clin Gastroenterol 1999; 28: 834.
  • 11
    Hawkey CJ. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis? Aliment Pharmacol Ther 2004; 20 (Suppl. 2): 5964.
  • 12
    Pilotto A, Franceschi M, Leandro G, et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004; 20: 10917.
  • 13
    Sung JJY. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Aliment Pharmacol Ther 2004; 20 (Suppl. 2): 6570.
  • 14
    Pilotto A, Salles N. Helicobacter pylori infection in geriatrics. Helicobacter 2002; 7 (Suppl. 1): 5662.
  • 15
    Murakami M, Saita H, Takahashi Y, et al. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients. J Clin Gastroenterol 1995; 20 (Suppl. 2): S7982.
  • 16
    Pilotto A, Di Mario F, Franceschi MF. Treatment of Helicobacter pylori infection in elderly subjects. Age Ageing 2000; 29: 1039.
  • 17
    Nawaz A, Mohammed I, Ahsan K, et al. Clostridium difficilis colitis associated with treatment of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 11756.
    Direct Link:
  • 18
    Larson JT, Skjelbo E, Gram LF. Helicobacter pylori infection. Lancet 1997; 349: 8789.
  • 19
    Teare JP, Booth JC, Brown JL, et al. Pseudomembranous colitis following clarithromycin therapy. Eur J Gastroenterol Hepatol 1995; 7: 2757.
  • 20
    Pilotto A, Di Mario F, Franceschi M, et al. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. Aliment Pharmacol Ther 1996; 10: 10217.
  • 21
    Pilotto A, Franceschi M, Leandro G, et al. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. J Gastroenterol Hepatol 1999; 14: 46875.
  • 22
    Pilotto A, Leandro G, Franceschi M, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 66773.
  • 23
    Pilotto A, Di Mario F, Franceschi M, et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000; 14: 107782.
  • 24
    Pilotto A, Franceschi M, Leandro G, et al. Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Aliment Pharmacol Ther 2001; 15: 10316.
  • 25
    Pilotto A, Franceschi M, Dal Bò N, et al. Comparison of three proton pump inhibitors in combination with amoxycillin and metronidazole for one week to cure Helicobacter pylori in the elderly. Digestion 1999; 59: A426.
  • 26
    Moshkowitz M, Brill S, Konikoff FM, et al. The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. J Am Geriatr Soc 1999; 47: 7202.
  • 27
    Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 7158.
  • 28
    Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17: 71926.
  • 29
    Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 124959.
  • 30
    Booker JA. Haematemesis and melaena in the elderly. Age Ageing 1983; 12: 4954.
  • 31
    Bansal SK, Gautam PC, Sahi SP, et al. Upper gastrointestinal hemorrage in the elderly: a record of 92 patients in a joint geriatric/surgical unit. Age Ageing 1987; 16: 27984.
  • 32
    Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 58691.
  • 33
    Kemppainen H, Raiha I, Kujari H, et al. Characteristics of Helicobacter pylori-negative and -positive peptic ulcer disease. Age Ageing 1998; 27: 42731.
  • 34
    Pilotto A, Franceschi M, Longoa MG, et al. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Dig Liver Dis 2004; 36: 66670.
  • 35
    De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001; 33: 6769.
  • 36
    Hassan C, De Francesco V, Zullo A, et al. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. Aliment Pharmacol Ther 2003; 18: 6416.
  • 37
    Focareta R, Forte G, Forte F, et al. Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection? Dig Liver Dis 2003; 35 (Suppl. 4): S33.
  • 38
    De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori infection does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 2004; 19: 40714.
  • 39
    De Francesco V, Zullo A, Hassan C, et al. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Dig Liver Dis 2004; 36: 3226.
  • 40
    De Francesco V, Della Valle N, Stoppino V, et al. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2004; 19: 9938.
  • 41
    Tulassay Z, Kryszewski A, Dite P, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001; 13: 145765.
  • 42
    Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 6038.